Related Experiment Video

Updated: Jun 10, 2026

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

HER-2/neu as a target for cancer vaccines

Constantin N Baxevanis1, Ioannis F Voutsas, Angelos D Gritzapis

  • 1Cancer Immunology & Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece. baxevanis@ciic.gr

Immunotherapy
|July 20, 2010
PubMed

Insights

HER-2/neu vaccines offer a novel treatment for HER-2/neu-positive cancers like breast and prostate. Clinical trials show these vaccines generate lasting T-cell immunity with minimal toxicity, paving the way for new cancer therapies.

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • HER-2/neu protein overexpression is implicated in aggressive breast and prostate cancers.
  • Current treatments for HER-2/neu-positive malignancies have limitations.
  • Targeting HER-2/neu offers a promising avenue for novel cancer therapies.

Purpose of the Study:

  • To evaluate the efficacy and safety of HER-2/neu-targeting vaccines in treating HER-2/neu-positive cancers.
  • To explore the potential of active immunotherapy using HER-2/neu vaccines.
  • To investigate the use of HER-2/neu vaccines in adjuvant settings for cancer relapse prevention.

Main Methods:

  • Development and testing of peptide and DNA vaccines targeting HER-2/neu extracellular and intracellular domains.
  • Phase I and II clinical trials to assess vaccine-induced immunity and toxicity.
  • Ex vivo expansion of HER-2/neu-specific T cells for adoptive immunotherapy.

Main Results:

  • HER-2/neu vaccines demonstrated the ability to generate durable T-cell anti-HER-2/neu immunity.
  • Clinical trials showed no significant toxicity or autoimmunity against normal tissues.
  • Early adjuvant trials indicated promising results in preventing breast cancer relapse.

Conclusions:

  • HER-2/neu vaccines represent a novel and safe therapeutic modality for HER-2/neu-positive malignancies.
  • Active immunization with HER-2/neu vaccines can induce protective anti-tumor immunity.
  • Future research directions include multiepitope vaccines and combination therapies for enhanced efficacy.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...